Vendor, San Diego, CA
Sorrento Therapeutics, Inc.
UEI KWEWLHZ59FL3, CAGE 5SPZ9
1 award and $0 obligated between February 8, 2024 and April 25, 2025, 100% under full and open competition, against 19.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93023C00024Definitive Contract, February 8, 2024, Full and Open Competition, 19 offers | National Institutes of Health NiaidNational Institutes of Health | BAA Research Area 004 - "development of in Vitro for Biodefense, Antimicrobial Resistant (Amr) Infections and Emerging Infectious Diseases"NAICS 541715, PSC AN12 | $0 |
- Places of performance
- California
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 2 across 1 awards